Metastatic ER+ Breast Cancer: Mechanisms of Resistance and Future Therapeutic Approaches
Endocrine therapy is the main treatment for hormone receptor-positive (HR+) breast cancer. However, advanced tumors develop resistance to endocrine therapy, rendering it ineffective as the disease progresses. There are several molecular mechanisms of primary and secondary endocrine resistance. Resis...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671474/ https://www.ncbi.nlm.nih.gov/pubmed/38003387 http://dx.doi.org/10.3390/ijms242216198 |